Fifth Report - Humanitarian crises monitoring: impact of coronavirus (interim findings)

The government accepts the recommendation, stating it will continue to fund existing global health programmes for previously identified diseases, including through investments in Gavi, the Global Fund, and the WHO. It views COVID-19 efforts as complementary to these goals.

The government affirms its commitment to eliminating gender-based violence, detailing existing programs, reoriented FCDO initiatives, and recent efforts like the £1.3 million Global Survivors Fund, thereby demonstrating ongoing leadership and action in this area.

The government commits to continuing its work in demonstrating UK leadership on the international stage, promoting a rules-based system, global security, human rights, and the rule of law, leveraging opportunities like the upcoming G7 Presidency.

The government disagrees with switching COVID-19 vaccine R&D funding from ODA, stating its allocation complies with DAC rules and is crucial for developing world access. It highlights ongoing efforts to tackle indirect impacts and existing support for health and education in developing countries.

The government rejects the recommendation not to count COVID-19 vaccine, treatment, and diagnostic (VTD) research funding as ODA, asserting its commitment to OECD DAC rules and ensuring VTDs are suitable and accessible for developing countries.

The government rejects the committee's view that ODA funding should be diverted from COVID-19 R&D. It highlights existing commitments to global health, including funding for Gavi and the Global Fund, without committing to lead a new holistic global health and nutrition strategy during its G7 Presidency.